Showing results (31-40 of 188) with videos related to
Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|January 1, 1997
Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometryJ Ramírez, K Ogan, M J RatainJournal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Simultaneous determination of 5-fluorouracil and uracil by high-performance liquid chromatography using four serial columnsL K House, J Ramírez, M J RatainCancer Research|August 1, 1986
Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancerR L Schilsky, K O'Laughlin, M J RatainCancer Surveys|January 1, 1993
Pharmacodynamic-pharmacokinetic relationships and therapeutic drug monitoringK Kobayashi, D I Jodrell, M J RatainClinical Pharmacology and Therapeutics|January 13, 2016
The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for EveryoneP H O'Donnell, K Danahey, M J RatainClinical Pharmacology and Therapeutics|January 1, 1987
Interpatient and intrapatient variability in vinblastine pharmacokineticsM J Ratain, N J Vogelzang, J A SinkuleCancer Chemotherapy and Pharmacology|January 1, 1997
Modulation of glucuronidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbitalE Gupta, X Wang, J Ramirez, et al.Clinical Pharmacology and Therapeutics|August 6, 2008
Nonprofit biomedical companiesR M Conti, D O Meltzer, M J RatainHematology/Oncology Clinics of North America|April 1, 1990
Hairy cell leukemia. Current managementL L Doane, M J Ratain, H M GolombJournal of the National Cancer Institute|November 16, 1994
Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trialsR Mick, N Lane, C Daugherty, et al.Pageof 19